NCT02334930View on ClinicalTrials.gov

Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
PEComaHemangioma
Interventions
OTHER

Biopsy

Trial Locations (1)

33000

CHU de Bordeaux, Bordeaux

All Listed Sponsors
collaborator

Ministry for Health and Solidarity, France

OTHER_GOV

collaborator

National Cancer Institute, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER

NCT02334930 - Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors | Biotech Hunter | Biotech Hunter